These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19118074)

  • 1. Prediction of cancer relapse after prostatectomy: use the postoperative nomogram.
    Fromont G
    Clin Cancer Res; 2009 Jan; 15(1):413; author reply 413-4. PubMed ID: 19118074
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating a marker's contribution to a nomogram: the GEMCaP example.
    Kattan MW
    Clin Cancer Res; 2010 Jan; 16(1):1-3. PubMed ID: 20028766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
    Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
    BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
    BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram to predict the development of a nomogram.
    Carden CP; Rosenthal MA
    BJU Int; 2008 Aug; 102(3):402. PubMed ID: 18702786
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
    Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
    BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.
    Froehner M; Koch R; Litz RJ; Wirth MP
    Urology; 2009 Mar; 73(3):610-3; discussion 613-4. PubMed ID: 19167030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PSA kinetics after total prostatectomy].
    Riedinger JM; Eche N; Fulla Y; Thuillier F
    Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More nomograms or better evidence of efficacy: what do we need in urologic oncology?
    Catto JW
    Eur Urol; 2008 Jul; 54(1):11-2. PubMed ID: 18262334
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomolecular markers of outcome prediction in prostate cancer.
    Lopergolo A; Zaffaroni N
    Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment on: Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.
    Briganti A
    Eur Urol; 2009 Oct; 56(4):667-8. PubMed ID: 19304374
    [No Abstract]   [Full Text] [Related]  

  • 12. The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.
    Capitanio U; Karakiewicz PI; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Int J Urol; 2009 May; 16(5):526-9. PubMed ID: 19389085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of syndecan-1 expression in patients treated with radical prostatectomy. Commentary.
    Brimo F; Vollmer RT; Bismar TA
    BJU Int; 2009 Jul; 104(1):125. PubMed ID: 19646129
    [No Abstract]   [Full Text] [Related]  

  • 16. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
    Winter A; Uphoff J; Henke RP; Wawroschek F
    Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas.
    de Castro SM; Biere SS; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
    Br J Surg; 2009 Apr; 96(4):417-23. PubMed ID: 19283741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
    D'Amico AV; Chen MH
    J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
    [No Abstract]   [Full Text] [Related]  

  • 20. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.